世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

造血幹細胞移植(HSCT)の世界市場 2023-2027


Global Hematopoietic Stem Cells Transplantation (HSCT) Market 2023-2027

造血幹細胞移植(HSCT)の世界市場 2023-2027 Technavioは、造血幹細胞移植(HSCT)市場を監視しており、2022年から2027年の間に2383.61万ドル、予測期間中のCAGRは6.5%で加速し成長すると予測しています。当レ... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechNavio
テクナビオ
2023年1月2日 US$2,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
159 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

造血幹細胞移植(HSCT)の世界市場 2023-2027
Technavioは、造血幹細胞移植(HSCT)市場を監視しており、2022年から2027年の間に2383.61万ドル、予測期間中のCAGRは6.5%で加速し成長すると予測しています。当レポートでは、造血幹細胞移植(HSCT)市場について、全体的な分析、市場規模や予測、トレンド、成長ドライバー、課題、さらに約25のベンダーをカバーするベンダー分析などを掲載しています。
現在の市場シナリオ、最新トレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、技術的に高度な機器の利用可能性、再生医療分野への投資の増加、造血幹細胞移植の件数の増加によって牽引されています。
Technavioの造血幹細胞移植(HSCT)市場は、以下のように区分されます:
用途別
- 骨髄移植
- 末梢血幹細胞移植
- 臍帯血移植
タイプ別
- 自家造血幹細胞移植
- 同種造血幹細胞移植(Allogeneic HSCT
地理的景観別
- 北アメリカ
- ヨーロッパ
- 亜細亜
- レスト・オブ・ワールド(ROW)
本調査では、今後数年間における造血幹細胞移植(HSCT)市場の成長を牽引する主要な理由の一つとして、個別化医療への需要の高まりを挙げています。また、罹患率や死亡率の低下、臍帯血バンクの登場は、市場の大きな需要につながると考えられます。
Technavioは、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。当レポートでは、造血幹細胞移植(HSCT)市場について、以下の分野を取り上げています:
- 造血幹細胞移植(HSCT)市場のサイジング
- 造血幹細胞移植(HSCT)市場予測
- 造血幹細胞移植(HSCT)市場の産業分析
Technavioの強固なベンダー分析は、クライアントの市場ポジションの向上に役立つように設計されており、これに沿って、本レポートでは、Athersys Inc.、Beike Biotechnology Co.Ltd.、bluebird bio Inc.、Cellular Biomedicine Group Inc.などの造血幹細胞移植(HSCT)市場の主要ベンダー数社の詳細分析を掲載している。Ltd.、bluebird bio Inc.、Cellular Biomedicine Group Inc.、FUJIFILM Corp.、Gamida Cell Ltd.、Lineage Cell Therapeutics Inc.、Lonza Group Ltd.、MEDIPOST Co.Ltd.、Merck and Co.Inc.、Mesoblast Ltd.、Pluristem Therapeutics Inc.、Sanofi SA、Sartorius CellGenix GmbH、Taiga Biotechnologies Inc.、Takeda Pharmaceutical Co.Ltd.、Talaris Therapeutics Inc.、ThermoGenesis Holdings Inc.、AllCells Corp.また、造血幹細胞移植(HSCT)市場の分析レポートには、今後の動向や市場成長に影響を与える課題についての情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/hematopoietic-stem-cells-transplantation-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析によって、複数のソースからのデータを調査、合成、要約する方法で、市場の詳細な画像を提示します。また、業界の主要なインフルエンサーを特定することで、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた詳細なベンダー選択方法と分析を提供します。

ページTOPに戻る


目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global hematopoietic stem cells transplantation (HSCT) market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global hematopoietic stem cells transplantation (HSCT) market 2017 - 2021 ($ million)
o 4.2 Application Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
o 4.3 Type Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Bone marrow transplant - Market size and forecast 2022-2027
o Exhibit 34: Chart on Bone marrow transplant - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Bone marrow transplant - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Bone marrow transplant - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Bone marrow transplant - Year-over-year growth 2022-2027 (%)
o 6.4 Peripheral blood stem cell transplant - Market size and forecast 2022-2027
o Exhibit 38: Chart on Peripheral blood stem cell transplant - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Peripheral blood stem cell transplant - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Peripheral blood stem cell transplant - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Peripheral blood stem cell transplant - Year-over-year growth 2022-2027 (%)
o 6.5 Cord blood transplant - Market size and forecast 2022-2027
o Exhibit 42: Chart on Cord blood transplant - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Cord blood transplant - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Cord blood transplant - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Cord blood transplant - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Application
o Exhibit 46: Market opportunity by Application ($ million)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 47: Chart on Type - Market share 2022-2027 (%)
o Exhibit 48: Data Table on Type - Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 49: Chart on Comparison by Type
o Exhibit 50: Data Table on Comparison by Type
o 7.3 Autologous HSCT - Market size and forecast 2022-2027
o Exhibit 51: Chart on Autologous HSCT - Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Autologous HSCT - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Autologous HSCT - Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Autologous HSCT - Year-over-year growth 2022-2027 (%)
o 7.4 Allogeneic HSCT - Market size and forecast 2022-2027
o Exhibit 55: Chart on Allogeneic HSCT - Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Allogeneic HSCT - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Allogeneic HSCT - Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Allogeneic HSCT - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Type
o Exhibit 59: Market opportunity by Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 63: Chart on Geographic comparison
o Exhibit 64: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 UK - Market size and forecast 2022-2027
o Exhibit 85: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 Canada - Market size and forecast 2022-2027
o Exhibit 93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.11 China - Market size and forecast 2022-2027
o Exhibit 97: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 101: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 102: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 104: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 105: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 106: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 107: Matrix on vendor position and classification
o 12.3 AllCells Corp.
o Exhibit 108: AllCells Corp. - Overview
o Exhibit 109: AllCells Corp. - Product / Service
o Exhibit 110: AllCells Corp. - Key offerings
o 12.4 Athersys Inc.
o Exhibit 111: Athersys Inc. - Overview
o Exhibit 112: Athersys Inc. - Product / Service
o Exhibit 113: Athersys Inc. - Key offerings
o 12.5 Beike Biotechnology Co. Ltd.
o Exhibit 114: Beike Biotechnology Co. Ltd. - Overview
o Exhibit 115: Beike Biotechnology Co. Ltd. - Product / Service
o Exhibit 116: Beike Biotechnology Co. Ltd. - Key offerings
o 12.6 bluebird bio Inc.
o Exhibit 117: bluebird bio Inc. - Overview
o Exhibit 118: bluebird bio Inc. - Product / Service
o Exhibit 119: bluebird bio Inc. - Key offerings
o 12.7 Cellular Biomedicine Group Inc.
o Exhibit 120: Cellular Biomedicine Group Inc. - Overview
o Exhibit 121: Cellular Biomedicine Group Inc. - Product / Service
o Exhibit 122: Cellular Biomedicine Group Inc. - Key offerings
o 12.8 FUJIFILM Corp.
o Exhibit 123: FUJIFILM Corp. - Overview
o Exhibit 124: FUJIFILM Corp. - Business segments
o Exhibit 125: FUJIFILM Corp. - Key news
o Exhibit 126: FUJIFILM Corp. - Key offerings
o Exhibit 127: FUJIFILM Corp. - Segment focus
o 12.9 Gamida Cell Ltd.
o Exhibit 128: Gamida Cell Ltd. - Overview
o Exhibit 129: Gamida Cell Ltd. - Product / Service
o Exhibit 130: Gamida Cell Ltd. - Key offerings
o 12.10 Lineage Cell Therapeutics Inc.
o Exhibit 131: Lineage Cell Therapeutics Inc. - Overview
o Exhibit 132: Lineage Cell Therapeutics Inc. - Product / Service
o Exhibit 133: Lineage Cell Therapeutics Inc. - Key offerings
o 12.11 Lonza Group Ltd.
o Exhibit 134: Lonza Group Ltd. - Overview
o Exhibit 135: Lonza Group Ltd. - Business segments
o Exhibit 136: Lonza Group Ltd. - Key news
o Exhibit 137: Lonza Group Ltd. - Key offerings
o Exhibit 138: Lonza Group Ltd. - Segment focus
o 12.12 MEDIPOST Co. Ltd.
o Exhibit 139: MEDIPOST Co. Ltd. - Overview
o Exhibit 140: MEDIPOST Co. Ltd. - Product / Service
o Exhibit 141: MEDIPOST Co. Ltd. - Key offerings
o 12.13 Merck and Co. Inc.
o Exhibit 142: Merck and Co. Inc. - Overview
o Exhibit 143: Merck and Co. Inc. - Business segments
o Exhibit 144: Merck and Co. Inc. - Key news
o Exhibit 145: Merck and Co. Inc. - Key offerings
o Exhibit 146: Merck and Co. Inc. - Segment focus
o 12.14 Mesoblast Ltd.
o Exhibit 147: Mesoblast Ltd. - Overview
o Exhibit 148: Mesoblast Ltd. - Product / Service
o Exhibit 149: Mesoblast Ltd. - Key offerings
o 12.15 Sanofi SA
o Exhibit 150: Sanofi SA - Overview
o Exhibit 151: Sanofi SA - Business segments
o Exhibit 152: Sanofi SA - Key news
o Exhibit 153: Sanofi SA - Key offerings
o Exhibit 154: Sanofi SA - Segment focus
o 12.16 Takeda Pharmaceutical Co. Ltd.
o Exhibit 155: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 156: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 157: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 158: Takeda Pharmaceutical Co. Ltd. - Key offerings
o 12.17 ThermoGenesis Holdings Inc.
o Exhibit 159: ThermoGenesis Holdings Inc. - Overview
o Exhibit 160: ThermoGenesis Holdings Inc. - Product / Service
o Exhibit 161: ThermoGenesis Holdings Inc. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 162: Inclusions checklist
o Exhibit 163: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 164: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 165: Research methodology
o Exhibit 166: Validation techniques employed for market sizing
o Exhibit 167: Information sources
o 13.5 List of abbreviations
o Exhibit 168: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global hematopoietic stem cells transplantation (HSCT) market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Application - Market share 2022-2027 (%)
Exhibits31: Data Table on Application - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Bone marrow transplant - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Bone marrow transplant - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Bone marrow transplant - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Bone marrow transplant - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Peripheral blood stem cell transplant - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Peripheral blood stem cell transplant - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Peripheral blood stem cell transplant - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Peripheral blood stem cell transplant - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Cord blood transplant - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Cord blood transplant - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Cord blood transplant - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Cord blood transplant - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Application ($ million)
Exhibits47: Chart on Type - Market share 2022-2027 (%)
Exhibits48: Data Table on Type - Market share 2022-2027 (%)
Exhibits49: Chart on Comparison by Type
Exhibits50: Data Table on Comparison by Type
Exhibits51: Chart on Autologous HSCT - Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Autologous HSCT - Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Autologous HSCT - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Autologous HSCT - Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Allogeneic HSCT - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Allogeneic HSCT - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Allogeneic HSCT - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Allogeneic HSCT - Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by Type ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ million)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: AllCells Corp. - Overview
Exhibits109: AllCells Corp. - Product / Service
Exhibits110: AllCells Corp. - Key offerings
Exhibits111: Athersys Inc. - Overview
Exhibits112: Athersys Inc. - Product / Service
Exhibits113: Athersys Inc. - Key offerings
Exhibits114: Beike Biotechnology Co. Ltd. - Overview
Exhibits115: Beike Biotechnology Co. Ltd. - Product / Service
Exhibits116: Beike Biotechnology Co. Ltd. - Key offerings
Exhibits117: bluebird bio Inc. - Overview
Exhibits118: bluebird bio Inc. - Product / Service
Exhibits119: bluebird bio Inc. - Key offerings
Exhibits120: Cellular Biomedicine Group Inc. - Overview
Exhibits121: Cellular Biomedicine Group Inc. - Product / Service
Exhibits122: Cellular Biomedicine Group Inc. - Key offerings
Exhibits123: FUJIFILM Corp. - Overview
Exhibits124: FUJIFILM Corp. - Business segments
Exhibits125: FUJIFILM Corp. - Key news
Exhibits126: FUJIFILM Corp. - Key offerings
Exhibits127: FUJIFILM Corp. - Segment focus
Exhibits128: Gamida Cell Ltd. - Overview
Exhibits129: Gamida Cell Ltd. - Product / Service
Exhibits130: Gamida Cell Ltd. - Key offerings
Exhibits131: Lineage Cell Therapeutics Inc. - Overview
Exhibits132: Lineage Cell Therapeutics Inc. - Product / Service
Exhibits133: Lineage Cell Therapeutics Inc. - Key offerings
Exhibits134: Lonza Group Ltd. - Overview
Exhibits135: Lonza Group Ltd. - Business segments
Exhibits136: Lonza Group Ltd. - Key news
Exhibits137: Lonza Group Ltd. - Key offerings
Exhibits138: Lonza Group Ltd. - Segment focus
Exhibits139: MEDIPOST Co. Ltd. - Overview
Exhibits140: MEDIPOST Co. Ltd. - Product / Service
Exhibits141: MEDIPOST Co. Ltd. - Key offerings
Exhibits142: Merck and Co. Inc. - Overview
Exhibits143: Merck and Co. Inc. - Business segments
Exhibits144: Merck and Co. Inc. - Key news
Exhibits145: Merck and Co. Inc. - Key offerings
Exhibits146: Merck and Co. Inc. - Segment focus
Exhibits147: Mesoblast Ltd. - Overview
Exhibits148: Mesoblast Ltd. - Product / Service
Exhibits149: Mesoblast Ltd. - Key offerings
Exhibits150: Sanofi SA - Overview
Exhibits151: Sanofi SA - Business segments
Exhibits152: Sanofi SA - Key news
Exhibits153: Sanofi SA - Key offerings
Exhibits154: Sanofi SA - Segment focus
Exhibits155: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits156: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits157: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits158: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits159: ThermoGenesis Holdings Inc. - Overview
Exhibits160: ThermoGenesis Holdings Inc. - Product / Service
Exhibits161: ThermoGenesis Holdings Inc. - Key offerings
Exhibits162: Inclusions checklist
Exhibits163: Exclusions checklist
Exhibits164: Currency conversion rates for US$
Exhibits165: Research methodology
Exhibits166: Validation techniques employed for market sizing
Exhibits167: Information sources
Exhibits168: List of abbreviations

 

ページTOPに戻る


 

Summary

Global Hematopoietic Stem Cells Transplantation (HSCT) Market 2023-2027
Technavio has been monitoring the hematopoietic stem cells transplantation (HSCT) market and is forecast to grow by $2383.61 mn during 2022-2027, accelerating at a CAGR of 6.5% during the forecast period. Our report on the hematopoietic stem cells transplantation (HSCT) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by availability of technologically advanced equipment, increasing investments in field of regenerative medicines, and rising number of HSCT.
Technavio's hematopoietic stem cells transplantation (HSCT) market is segmented as below:
By Application
• Bone marrow transplant
• Peripheral blood stem cell transplant
• Cord blood transplant
By Type
• Autologous HSCT
• Allogeneic HSCT
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the growing demand for personalized medicine as one of the prime reasons driving the hematopoietic stem cells transplantation (HSCT) market growth during the next few years. Also, decreasing morbidity and mortality rate and advent of cord blood banking will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the hematopoietic stem cells transplantation (HSCT) market covers the following areas:
• Hematopoietic stem cells transplantation (HSCT) market sizing
• Hematopoietic stem cells transplantation (HSCT) market forecast
• Hematopoietic stem cells transplantation (HSCT) market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hematopoietic stem cells transplantation (HSCT) market vendors that include Athersys Inc., Beike Biotechnology Co. Ltd., bluebird bio Inc., Cellular Biomedicine Group Inc., FUJIFILM Corp., Gamida Cell Ltd., Lineage Cell Therapeutics Inc., Lonza Group Ltd., MEDIPOST Co. Ltd., Merck and Co. Inc., Mesoblast Ltd., Pluristem Therapeutics Inc., Sanofi SA, Sartorius CellGenix GmbH, Taiga Biotechnologies Inc., Takeda Pharmaceutical Co. Ltd., Talaris Therapeutics Inc., ThermoGenesis Holdings Inc., and AllCells Corp. Also, the hematopoietic stem cells transplantation (HSCT) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/hematopoietic-stem-cells-transplantation-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.



ページTOPに戻る


Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global hematopoietic stem cells transplantation (HSCT) market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global hematopoietic stem cells transplantation (HSCT) market 2017 - 2021 ($ million)
o 4.2 Application Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
o 4.3 Type Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Bone marrow transplant - Market size and forecast 2022-2027
o Exhibit 34: Chart on Bone marrow transplant - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Bone marrow transplant - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Bone marrow transplant - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Bone marrow transplant - Year-over-year growth 2022-2027 (%)
o 6.4 Peripheral blood stem cell transplant - Market size and forecast 2022-2027
o Exhibit 38: Chart on Peripheral blood stem cell transplant - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Peripheral blood stem cell transplant - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Peripheral blood stem cell transplant - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Peripheral blood stem cell transplant - Year-over-year growth 2022-2027 (%)
o 6.5 Cord blood transplant - Market size and forecast 2022-2027
o Exhibit 42: Chart on Cord blood transplant - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Cord blood transplant - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Cord blood transplant - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Cord blood transplant - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Application
o Exhibit 46: Market opportunity by Application ($ million)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 47: Chart on Type - Market share 2022-2027 (%)
o Exhibit 48: Data Table on Type - Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 49: Chart on Comparison by Type
o Exhibit 50: Data Table on Comparison by Type
o 7.3 Autologous HSCT - Market size and forecast 2022-2027
o Exhibit 51: Chart on Autologous HSCT - Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Autologous HSCT - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Autologous HSCT - Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Autologous HSCT - Year-over-year growth 2022-2027 (%)
o 7.4 Allogeneic HSCT - Market size and forecast 2022-2027
o Exhibit 55: Chart on Allogeneic HSCT - Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Allogeneic HSCT - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Allogeneic HSCT - Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Allogeneic HSCT - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Type
o Exhibit 59: Market opportunity by Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 63: Chart on Geographic comparison
o Exhibit 64: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 UK - Market size and forecast 2022-2027
o Exhibit 85: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 Canada - Market size and forecast 2022-2027
o Exhibit 93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.11 China - Market size and forecast 2022-2027
o Exhibit 97: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 101: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 102: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 104: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 105: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 106: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 107: Matrix on vendor position and classification
o 12.3 AllCells Corp.
o Exhibit 108: AllCells Corp. - Overview
o Exhibit 109: AllCells Corp. - Product / Service
o Exhibit 110: AllCells Corp. - Key offerings
o 12.4 Athersys Inc.
o Exhibit 111: Athersys Inc. - Overview
o Exhibit 112: Athersys Inc. - Product / Service
o Exhibit 113: Athersys Inc. - Key offerings
o 12.5 Beike Biotechnology Co. Ltd.
o Exhibit 114: Beike Biotechnology Co. Ltd. - Overview
o Exhibit 115: Beike Biotechnology Co. Ltd. - Product / Service
o Exhibit 116: Beike Biotechnology Co. Ltd. - Key offerings
o 12.6 bluebird bio Inc.
o Exhibit 117: bluebird bio Inc. - Overview
o Exhibit 118: bluebird bio Inc. - Product / Service
o Exhibit 119: bluebird bio Inc. - Key offerings
o 12.7 Cellular Biomedicine Group Inc.
o Exhibit 120: Cellular Biomedicine Group Inc. - Overview
o Exhibit 121: Cellular Biomedicine Group Inc. - Product / Service
o Exhibit 122: Cellular Biomedicine Group Inc. - Key offerings
o 12.8 FUJIFILM Corp.
o Exhibit 123: FUJIFILM Corp. - Overview
o Exhibit 124: FUJIFILM Corp. - Business segments
o Exhibit 125: FUJIFILM Corp. - Key news
o Exhibit 126: FUJIFILM Corp. - Key offerings
o Exhibit 127: FUJIFILM Corp. - Segment focus
o 12.9 Gamida Cell Ltd.
o Exhibit 128: Gamida Cell Ltd. - Overview
o Exhibit 129: Gamida Cell Ltd. - Product / Service
o Exhibit 130: Gamida Cell Ltd. - Key offerings
o 12.10 Lineage Cell Therapeutics Inc.
o Exhibit 131: Lineage Cell Therapeutics Inc. - Overview
o Exhibit 132: Lineage Cell Therapeutics Inc. - Product / Service
o Exhibit 133: Lineage Cell Therapeutics Inc. - Key offerings
o 12.11 Lonza Group Ltd.
o Exhibit 134: Lonza Group Ltd. - Overview
o Exhibit 135: Lonza Group Ltd. - Business segments
o Exhibit 136: Lonza Group Ltd. - Key news
o Exhibit 137: Lonza Group Ltd. - Key offerings
o Exhibit 138: Lonza Group Ltd. - Segment focus
o 12.12 MEDIPOST Co. Ltd.
o Exhibit 139: MEDIPOST Co. Ltd. - Overview
o Exhibit 140: MEDIPOST Co. Ltd. - Product / Service
o Exhibit 141: MEDIPOST Co. Ltd. - Key offerings
o 12.13 Merck and Co. Inc.
o Exhibit 142: Merck and Co. Inc. - Overview
o Exhibit 143: Merck and Co. Inc. - Business segments
o Exhibit 144: Merck and Co. Inc. - Key news
o Exhibit 145: Merck and Co. Inc. - Key offerings
o Exhibit 146: Merck and Co. Inc. - Segment focus
o 12.14 Mesoblast Ltd.
o Exhibit 147: Mesoblast Ltd. - Overview
o Exhibit 148: Mesoblast Ltd. - Product / Service
o Exhibit 149: Mesoblast Ltd. - Key offerings
o 12.15 Sanofi SA
o Exhibit 150: Sanofi SA - Overview
o Exhibit 151: Sanofi SA - Business segments
o Exhibit 152: Sanofi SA - Key news
o Exhibit 153: Sanofi SA - Key offerings
o Exhibit 154: Sanofi SA - Segment focus
o 12.16 Takeda Pharmaceutical Co. Ltd.
o Exhibit 155: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 156: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 157: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 158: Takeda Pharmaceutical Co. Ltd. - Key offerings
o 12.17 ThermoGenesis Holdings Inc.
o Exhibit 159: ThermoGenesis Holdings Inc. - Overview
o Exhibit 160: ThermoGenesis Holdings Inc. - Product / Service
o Exhibit 161: ThermoGenesis Holdings Inc. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 162: Inclusions checklist
o Exhibit 163: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 164: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 165: Research methodology
o Exhibit 166: Validation techniques employed for market sizing
o Exhibit 167: Information sources
o 13.5 List of abbreviations
o Exhibit 168: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global hematopoietic stem cells transplantation (HSCT) market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Application - Market share 2022-2027 (%)
Exhibits31: Data Table on Application - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Bone marrow transplant - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Bone marrow transplant - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Bone marrow transplant - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Bone marrow transplant - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Peripheral blood stem cell transplant - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Peripheral blood stem cell transplant - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Peripheral blood stem cell transplant - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Peripheral blood stem cell transplant - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Cord blood transplant - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Cord blood transplant - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Cord blood transplant - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Cord blood transplant - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Application ($ million)
Exhibits47: Chart on Type - Market share 2022-2027 (%)
Exhibits48: Data Table on Type - Market share 2022-2027 (%)
Exhibits49: Chart on Comparison by Type
Exhibits50: Data Table on Comparison by Type
Exhibits51: Chart on Autologous HSCT - Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Autologous HSCT - Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Autologous HSCT - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Autologous HSCT - Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Allogeneic HSCT - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Allogeneic HSCT - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Allogeneic HSCT - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Allogeneic HSCT - Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by Type ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ million)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: AllCells Corp. - Overview
Exhibits109: AllCells Corp. - Product / Service
Exhibits110: AllCells Corp. - Key offerings
Exhibits111: Athersys Inc. - Overview
Exhibits112: Athersys Inc. - Product / Service
Exhibits113: Athersys Inc. - Key offerings
Exhibits114: Beike Biotechnology Co. Ltd. - Overview
Exhibits115: Beike Biotechnology Co. Ltd. - Product / Service
Exhibits116: Beike Biotechnology Co. Ltd. - Key offerings
Exhibits117: bluebird bio Inc. - Overview
Exhibits118: bluebird bio Inc. - Product / Service
Exhibits119: bluebird bio Inc. - Key offerings
Exhibits120: Cellular Biomedicine Group Inc. - Overview
Exhibits121: Cellular Biomedicine Group Inc. - Product / Service
Exhibits122: Cellular Biomedicine Group Inc. - Key offerings
Exhibits123: FUJIFILM Corp. - Overview
Exhibits124: FUJIFILM Corp. - Business segments
Exhibits125: FUJIFILM Corp. - Key news
Exhibits126: FUJIFILM Corp. - Key offerings
Exhibits127: FUJIFILM Corp. - Segment focus
Exhibits128: Gamida Cell Ltd. - Overview
Exhibits129: Gamida Cell Ltd. - Product / Service
Exhibits130: Gamida Cell Ltd. - Key offerings
Exhibits131: Lineage Cell Therapeutics Inc. - Overview
Exhibits132: Lineage Cell Therapeutics Inc. - Product / Service
Exhibits133: Lineage Cell Therapeutics Inc. - Key offerings
Exhibits134: Lonza Group Ltd. - Overview
Exhibits135: Lonza Group Ltd. - Business segments
Exhibits136: Lonza Group Ltd. - Key news
Exhibits137: Lonza Group Ltd. - Key offerings
Exhibits138: Lonza Group Ltd. - Segment focus
Exhibits139: MEDIPOST Co. Ltd. - Overview
Exhibits140: MEDIPOST Co. Ltd. - Product / Service
Exhibits141: MEDIPOST Co. Ltd. - Key offerings
Exhibits142: Merck and Co. Inc. - Overview
Exhibits143: Merck and Co. Inc. - Business segments
Exhibits144: Merck and Co. Inc. - Key news
Exhibits145: Merck and Co. Inc. - Key offerings
Exhibits146: Merck and Co. Inc. - Segment focus
Exhibits147: Mesoblast Ltd. - Overview
Exhibits148: Mesoblast Ltd. - Product / Service
Exhibits149: Mesoblast Ltd. - Key offerings
Exhibits150: Sanofi SA - Overview
Exhibits151: Sanofi SA - Business segments
Exhibits152: Sanofi SA - Key news
Exhibits153: Sanofi SA - Key offerings
Exhibits154: Sanofi SA - Segment focus
Exhibits155: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits156: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits157: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits158: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits159: ThermoGenesis Holdings Inc. - Overview
Exhibits160: ThermoGenesis Holdings Inc. - Product / Service
Exhibits161: ThermoGenesis Holdings Inc. - Key offerings
Exhibits162: Inclusions checklist
Exhibits163: Exclusions checklist
Exhibits164: Currency conversion rates for US$
Exhibits165: Research methodology
Exhibits166: Validation techniques employed for market sizing
Exhibits167: Information sources
Exhibits168: List of abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15 10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る